Full text is available at the source.
Abstract
A profound taxonomic shift in the microbiota of patients with ALS is characterized by severe depletion of protective bacteria and enrichment of pro-inflammatory strains.
- Patients with ALS exhibit significant changes in gut microbiota, including loss of beneficial bacteria that produce butyrate.
- Dysbiosis in ALS is linked to damage in the intestinal lining and disruption of tight junction proteins, resulting in a 'leaky gut.'
- The systemic release of bacterial components like lipopolysaccharides may lead to inflammation in the nervous system and increased neuron death.
- Therapeutic approaches such as Fecal Microbiota Transplantation and specific diets have shown potential in improving gut health and reducing anxiety in ALS patients.
- There is a notable research gap regarding the detailed structure of the enteric nervous system in ALS, indicating a need for further investigation.
Simplified